Mayo Clinic and GE HealthCare
(Nasdaq: GEHC)
today announced a strategic collaboration aimed at improving radiology practice and therapy delivery.
It marks the second collaboration between GE HealthCare and a major hospital this month alone. Last week, the company announced an AI-focused partnership with Massachusetts General Hospital.
The Strategic Collaboration for Innovation in Medical Imaging and Theranostics covers research and product development programs. It includes Mayo Clinic and GE HealthCare scientists, technology developers, clinicians and other healthcare providers.
Mayo Clinic and GE HealthCare aim to better equip clinicians with technology to precisely diagnose and treat medical conditions. They want to personalize the patient experience at each step of the care journey, according to a news release. Mayo and GE HealthCare said they seek to translate novel technologies and approaches to medical imaging and theranostics.
“We are at a critical time in healthcare – technology is rapidly evolving, and we have a responsibility to drive healthcare capabilities through clinical translation and adoption of advanced technologies,” said Dr. Matthew Callstrom, chair of Radiology at Mayo Clinic in Rochester, Minnesota. “This collaboration brings our research and clinical teams’ expertise and feedback closer to product development and commercialization of innovation, ultimately accelerating the rate of translation of our research to patient care and offering greater opportunity for global impact.”
More about the Mayo Clinic – GE HealthCare collaboration
Building on a longstanding history between the two organizations, the latest development focuses on four core areas. The collaboration takes place at Mayo Clinic’s Rochester, Minnesota campus.
First, Mayo Clinic and GE HealthCare want to rapidly accelerate the development and clinical translation of advanced magnetic resonance (MR) technologies and techniques. With this, they look to transform patient care through AI-enabled exams from order to report.
Second, they aim to transform cancer care through precise imaging and dosimetry of highly targeted theranostic agents. They believe they can enable broader access through more efficient radioisotope production.
The third goal is to make diagnostic and interventional ultrasound easier and faster to use. All the while, the organizations hope to advance automation and quantification. This could improve patient access, consistency of care and clinician experience.
Finally, Mayo Clinic and GE HealthCare said they want to leverage multi-modal data, AI and digital health platforms. They seek to improve the patient imaging experience across the care continuum. Using these assets can streamline clinical operations and support more personalized diagnosis and therapy.
“Mayo Clinic is globally acknowledged to be among the best in healthcare and care innovation. By collaborating with their scientists, inventors and healthcare providers, we will accelerate innovation and increase the clinical impact of our technologies beyond what either of our organizations could achieve independently,” said Jan Makela, president and CEO of Imaging, GE HealthCare.
